Related Experiment Video
Updated: May 28, 2025
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
27.1K
Nonfistulizing Perianal Crohn's Disease.
Emily Simon1, Emily Steinhagen2
1Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Clinics in Colon and Rectal Surgery
|February 13, 2025
Summary
Perianal Crohn
Area of Science:
- Gastroenterology and immunology
- Colorectal surgery
- Patient quality of life studies
Background:
- Perianal Crohn's disease (CD) encompasses various non-fistulizing conditions like fissures, ulcers, skin tags, and anal strictures.
- These manifestations significantly impair patient quality of life due to pain, drainage, bleeding, and hygiene difficulties.
- Secondary sexual and defecatory dysfunction can arise from perianal CD symptoms.
Purpose of the Study:
- To outline the spectrum of nonfistulizing perianal Crohn's disease (CD).
- To highlight the debilitating symptoms and impact on quality of life.
- To emphasize the need for a comprehensive management approach.
Main Methods:
- Review of clinical manifestations of perianal Crohn's disease.
- Analysis of patient-reported symptoms and quality of life impacts.
- Discussion of optimal patient care strategies.
Main Results:
- Non-fistulizing perianal Crohn's disease presents with diverse sequelae including fissures, ulcers, skin tags, and strictures.
- Symptoms such as pain, drainage, and bleeding profoundly affect daily living and quality of life.
- Management necessitates detailed assessment and multidisciplinary collaboration.
Conclusions:
- Perianal Crohn's disease requires a structured, multidisciplinary approach for effective symptom management.
- Optimizing quality of life is a primary goal in treating perianal manifestations of CD.
- Comprehensive care, including history, examination, and team-based strategies, is crucial for patient well-being.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
171
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
171
01:21Inflammatory Bowel Disease V: Surgical Management
101
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
101
01:17Chronic Bowel Disorders: Introduction
384
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
384
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
126
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
126
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
94
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
94
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114